FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W93356475> ?p ?o ?g. }

• W93356475 endingPage "986" @default.
• W93356475 startingPage "977" @default.
• W93356475 abstract "The purpose of this study was to test the lipid depletion hypothesis and to establish the time course of change in carotid plaque morphology and composition during lipid therapy using high-resolution magnetic resonance imaging (MRI). Lipid therapy is thought to improve plaque stability and reduce cardiovascular events by targeting the plaque rupture risk features such as large lipid core, thin fibrous cap, and high level of inflammatory infiltrates. However, the plaque stabilizing process during lipid therapy has not been clearly demonstrated in humans and in vivo. Subjects with coronary or carotid artery disease, apolipoprotein B ≥120 mg/dl, and lipid treatment history <1 year, were randomly assigned to atorvastatin monotherapy or to atorvastatin-based combination therapies with appropriate placebos for 3 years. All subjects underwent high-resolution, multicontrast bilateral carotid MRI scans at baseline and annually for 3 years. All images were analyzed for quantification of wall area and plaque composition blinded to therapy, laboratory results, and clinical course. After 3 years of lipid therapy, the 33 subjects with measurable lipid-rich necrotic core (LRNC) at baseline had a significant reduction in plaque lipid content: LRNC volume decreased from 60.4 ± 59.5 mm3 to 37.4 ± 69.5 mm3 (p < 0.001) and %LRNC (LRNC area/wall area in the lipid-rich regions) from 14.2 ± 7.0% to 7.4 ± 8.2% (p < 0.001). The time course showed that %LRNC decreased by 3.2 (p < 0.001) in the first year, by 3.0 (p = 0.005) in the second year, and by 0.91 (p = 0.2) in the third year. Changes in LRNC volume followed the same pattern. Percent wall volume (100 × wall/outer wall, a ratio of volumes) in the lipid-rich regions significantly decreased from 52.3 ± 8.5% to 48.6 ± 9.7% (p = 0.002). Slices containing LRNC had significantly more percent wall volume reduction than those without (−4.7% vs. −1.4%, p = 0.02). Intensive lipid therapy significantly depletes carotid plaque lipid. Statistically significant plaque lipid depletion is observed after 1 year of treatment and continues in the second year, and precedes plaque regression. (Using Magnetic Resonance Imaging to Evaluate Carotid Artery Plaque Composition in People Receiving Cholesterol-Lowering Medications [The CPC Study]; NCT00715273)." @default.
• W93356475 created "2016-06-24" @default.
• W93356475 creator A5004951534 @default.
• W93356475 creator A5008769328 @default.
• W93356475 creator A5020239292 @default.
• W93356475 creator A5027628995 @default.
• W93356475 creator A5064625850 @default.
• W93356475 creator A5066222674 @default.
• W93356475 creator A5066810979 @default.
• W93356475 creator A5069055892 @default.
• W93356475 creator A5078439776 @default.
• W93356475 creator A5080240923 @default.
• W93356475 creator A5083576707 @default.
• W93356475 creator A5083978504 @default.
• W93356475 creator A5088989138 @default.
• W93356475 date "2011-09-01" @default.
• W93356475 modified "2023-10-05" @default.
• W93356475 title "MR Imaging of Carotid Plaque Composition During Lipid-Lowering Therapy" @default.
• W93356475 cites W1553634909 @default.
• W93356475 cites W183477746 @default.
• W93356475 cites W1968240228 @default.
• W93356475 cites W1977101329 @default.
• W93356475 cites W1978644984 @default.
• W93356475 cites W2003287898 @default.
• W93356475 cites W2008397657 @default.
• W93356475 cites W2019711911 @default.
• W93356475 cites W2026856116 @default.
• W93356475 cites W2027423064 @default.
• W93356475 cites W2033931260 @default.
• W93356475 cites W2035142337 @default.
• W93356475 cites W2036146998 @default.
• W93356475 cites W2046991199 @default.
• W93356475 cites W2057135362 @default.
• W93356475 cites W2066772034 @default.
• W93356475 cites W2082917808 @default.
• W93356475 cites W2091814080 @default.
• W93356475 cites W2093664978 @default.
• W93356475 cites W2101267898 @default.
• W93356475 cites W2103042683 @default.
• W93356475 cites W2110521364 @default.
• W93356475 cites W2118086723 @default.
• W93356475 cites W2118220211 @default.
• W93356475 cites W2119324119 @default.
• W93356475 cites W2120289695 @default.
• W93356475 cites W2130771193 @default.
• W93356475 cites W2135912447 @default.
• W93356475 cites W2136927467 @default.
• W93356475 cites W2164807534 @default.
• W93356475 cites W2166833304 @default.
• W93356475 cites W4361865010 @default.
• W93356475 doi "https://doi.org/10.1016/j.jcmg.2011.06.013" @default.
• W93356475 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3638021" @default.
• W93356475 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21920335" @default.
• W93356475 hasPublicationYear "2011" @default.
• W93356475 type Work @default.
• W93356475 sameAs 93356475 @default.
• W93356475 citedByCount "139" @default.
• W93356475 countsByYear W933564752012 @default.
• W93356475 countsByYear W933564752013 @default.
• W93356475 countsByYear W933564752014 @default.
• W93356475 countsByYear W933564752015 @default.
• W93356475 countsByYear W933564752016 @default.
• W93356475 countsByYear W933564752017 @default.
• W93356475 countsByYear W933564752018 @default.
• W93356475 countsByYear W933564752019 @default.
• W93356475 countsByYear W933564752020 @default.
• W93356475 countsByYear W933564752021 @default.
• W93356475 countsByYear W933564752022 @default.
• W93356475 countsByYear W933564752023 @default.
• W93356475 crossrefType "journal-article" @default.
• W93356475 hasAuthorship W93356475A5004951534 @default.
• W93356475 hasAuthorship W93356475A5008769328 @default.
• W93356475 hasAuthorship W93356475A5020239292 @default.
• W93356475 hasAuthorship W93356475A5027628995 @default.
• W93356475 hasAuthorship W93356475A5064625850 @default.
• W93356475 hasAuthorship W93356475A5066222674 @default.
• W93356475 hasAuthorship W93356475A5066810979 @default.
• W93356475 hasAuthorship W93356475A5069055892 @default.
• W93356475 hasAuthorship W93356475A5078439776 @default.
• W93356475 hasAuthorship W93356475A5080240923 @default.
• W93356475 hasAuthorship W93356475A5083576707 @default.
• W93356475 hasAuthorship W93356475A5083978504 @default.
• W93356475 hasAuthorship W93356475A5088989138 @default.
• W93356475 hasBestOaLocation W933564751 @default.
• W93356475 hasConcept C126322002 @default.
• W93356475 hasConcept C126838900 @default.
• W93356475 hasConcept C142724271 @default.
• W93356475 hasConcept C143409427 @default.
• W93356475 hasConcept C2777482532 @default.
• W93356475 hasConcept C2778163477 @default.
• W93356475 hasConcept C2778270857 @default.
• W93356475 hasConcept C2778710248 @default.
• W93356475 hasConcept C2779179121 @default.
• W93356475 hasConcept C71924100 @default.
• W93356475 hasConceptScore W93356475C126322002 @default.
• W93356475 hasConceptScore W93356475C126838900 @default.
• W93356475 hasConceptScore W93356475C142724271 @default.
• W93356475 hasConceptScore W93356475C143409427 @default.

• next